Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,626,373 | 1,662,991 | 1,033,654 | 1,018,225 | 860,469 |
| Cost of Goods | 1,273,376 | 946,588 | 507,476 | 420,770 | 508,065 |
| Gross Profit | 352,997 | 716,403 | 526,178 | 597,455 | 352,404 |
| Operating Expenses | 602,055 | 736,664 | 281,551 | 313,344 | 282,901 |
| Operating Income | -248,682 | -19,673 | 245,103 | 284,881 | 69,568 |
| Interest Expense | 168,205 | 143,571 | 71,061 | 55,283 | 26,226 |
| Other Income | 196,645 | -39,478 | -2,719 | -14,777 | 16,026 |
| Pre-tax Income | -220,242 | -202,722 | 171,323 | 214,821 | 59,368 |
| Income Tax | 383,331 | -1,419 | 1,998 | 5,395 | 20,371 |
| Net Income Continuous | -603,573 | -201,303 | 169,325 | 209,426 | 38,997 |
| Minority Interests | -241,656 | -31,577 | 1,677 | 2,048 | N/A |
| Net Income | $-361,917 | $-169,726 | $167,648 | $207,378 | $38,997 |
| EPS Basic Total Ops | -2.74 | -0.16 | N/A | N/A | 0.56 |
| EPS Basic Continuous Ops | -4.57 | -1.58 | N/A | N/A | 0.56 |
| EPS Diluted Total Ops | -2.74 | -0.16 | N/A | N/A | 0.54 |
| EPS Diluted Continuous Ops | -4.57 | -1.58 | N/A | N/A | 0.54 |
| EPS Diluted Before Non-Recurring Items | 0.27 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,424 | $134,012 | $295,624 | $320,952 | $138,205 |